TGFB1 anticorps (AA 336-385)
-
- Antigène Voir toutes TGFB1 Anticorps
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Épitope
- AA 336-385
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TGFB1 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Specificité
-
TGF beta1 Antibody detects endogenous levels of total TGF beta1 protein.
- Purification
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
- Pureté
- > 95 %
- Immunogène
- The antiserum was produced against synthesized peptide derived from human TGF beta1.
- Isotype
- IgG
- Top Product
- Discover our top product TGFB1 Anticorps primaire
-
-
- Indications d'application
- WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:5000
- Commentaires
-
Unigene-Number: Hs.645227 (NCBI Gene Symbol: TGFB1)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Stable at -20°C for at least 1 year.
- Date de péremption
- 12 months
-
-
Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." dans: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
: "
-
Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis." dans: Cellular immunology, Vol. 279, Issue 1, pp. 70-7, (2012) (PubMed).
-
- Antigène
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
- Autre désignation
- TGF Beta1 (TGFB1 Produits)
- Synonymes
- anticorps CED, anticorps DPD1, anticorps LAP, anticorps TGFB, anticorps TGFbeta, anticorps TGF-beta, anticorps TGF-BETA-1, anticorps TGF-beta5, anticorps ced, anticorps dpd1, anticorps lap, anticorps tgf-beta, anticorps tgfb, anticorps tgfb5, anticorps tgfbeta, anticorps TGF-beta1, anticorps TGFbeta1, anticorps Tgfb, anticorps Tgfb-1, anticorps ai39657, anticorps tgfb1, anticorps wu:fb13a07, anticorps xx:ai39657, anticorps TGFB1, anticorps csd, anticorps cdb1, anticorps cdg2, anticorps csd1, anticorps csd2, anticorps csd3, anticorps ebmd, anticorps lcd1, anticorps bigh3, anticorps cdgg1, anticorps betaig-h3, anticorps TGFB4, anticorps transforming growth factor beta 1, anticorps transforming growth factor beta-1, anticorps transforming growth factor beta 1 L homeolog, anticorps transforming growth factor, beta 1, anticorps transforming growth factor, beta 1a, anticorps transforming growth factor beta induced L homeolog, anticorps TGFB1, anticorps Tgfb1, anticorps tgfb1.L, anticorps tgfb1a, anticorps tgfbi.L
- Sujet
-
Synonyms: CED, diaphyseal dysplasia 1, progressive, DPD1, TGF-beta 1, TGFB, transforming growth factor, beta 1, transforming growth factor, beta 1 (Camurati-Engelmann disease)
NCBI Gene Symbol: TGFB1
- Poids moléculaire
- 44 kDa
- ID gène
- 7040
- OMIM
- 131300
- UniProt
- P01137
- Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
-